US Stock MarketDetailed Quotes

HOWL Werewolf Therapeutics

Watchlist

1.900
+0.120+6.74%

Close Nov 22 16:00 ET

1.960
+0.060+3.16%

Post 20:02 ET

84.67MMarket Cap-1250P/E (TTM)

Werewolf Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Werewolf Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 375.000K	--
--	2024/Q4	-- / 301.590K	--
--	2024/Q3	0.000 / 709.320K	--
--	2024/Q2	1.143M / 841.780K	--
--	2024/Q1	742.000K / 1.457M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 375.000K--

--2024/Q4-- / 301.590K--

--2024/Q30.000 / 709.320K--

--2024/Q21.143M / 841.780K--

--2024/Q1742.000K / 1.457M--

Unlock Free Earnings Estimates

Open Account

Werewolf Therapeutics Earnings Reports

Werewolf Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7 09:13 ET

Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7 09:08 ET

Werewolf Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 07:14 ET

Werewolf Therapeutics | 8-K: Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 8 07:09 ET

Analyst Rating

Updated: Nov 11, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall